Appili Therapeutics Inc.

TSX:APLI Stok Raporu

Piyasa değeri: CA$4.2m

Appili Therapeutics Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Don Cilla

İcra Kurulu Başkanı

CA$622.6k

Toplam tazminat

CEO maaş yüzdesi80.4%
CEO görev süresi2yrs
CEO sahipliği0.06%
Yönetim ortalama görev süresi2yrs
Yönetim Kurulu ortalama görev süresi5.5yrs

Son yönetim güncellemeleri

Recent updates

Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Mar 24
Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Dec 09
Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

CEO Tazminat Analizi

Don Cilla'un ücretlendirmesi Appili Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CA$4m

Mar 31 2024CA$623kCA$501k

-CA$4m

Dec 31 2023n/an/a

-CA$5m

Sep 30 2023n/an/a

-CA$8m

Jun 30 2023n/an/a

-CA$8m

Mar 31 2023CA$608kCA$433k

-CA$9m

Dec 31 2022n/an/a

-CA$10m

Sep 30 2022n/an/a

-CA$11m

Jun 30 2022n/an/a

-CA$20m

Mar 31 2022CA$747kCA$477k

-CA$25m

Dec 31 2021n/an/a

-CA$27m

Sep 30 2021n/an/a

-CA$28m

Jun 30 2021n/an/a

-CA$19m

Mar 31 2021CA$627kCA$170k

-CA$14m

Tazminat ve Piyasa: Don's total compensation ($USD446.10K) is above average for companies of similar size in the Canadian market ($USD171.96K).

Tazminat ve Kazançlar: Don's compensation has increased whilst the company is unprofitable.

CEO

Don Cilla

2yrs

Görev süresi

CA$622,595

Tazminat

Dr. Donald D. Cilla, also known as Don, Jr., PharmD, MBA, serves as Chief Executive Officer, President and Director at Appili Therapeutics Inc. since November 13, 2022 and served as its Chief Development O...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Donald Cilla
CEO, President & Director2yrsCA$622.60k0.062%
CA$ 2.6k
Kenneth Howling
Chief Financial Officer3yrsCA$499.44kVeri yok
Gary Nabors
Chief Development Officer1.6yrsCA$548.01kVeri yok
Carl Gelhaus
Director of Non-Clinical Researchno dataCA$301.26kVeri yok
Arthur Baran
Director of New Product Developmentno dataCA$313.76kVeri yok

2.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim: APLI's management team is considered experienced (2 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Donald Cilla
CEO, President & Director2yrsCA$622.60k0.062%
CA$ 2.6k
Lidija Marusic
Board Observer5.5yrsVeri yokVeri yok
Prakash Gowd
Independent Directorless than a yearCA$30.23kVeri yok
Lynn Silver
Member of Advisory Boardno dataVeri yokVeri yok
Dean Shinabarger
Member of Advisory Boardno dataVeri yokVeri yok
Brian Bloom
Independent Director9.5yrsCA$63.10kVeri yok
Juergen Froehlich
Independent Director4.8yrsCA$84.10kVeri yok
Armand Balboni
Chairman of the Board5.8yrsCA$39.00kVeri yok
Theresa Matkovits
Lead Independent Director6.1yrsCA$131.60kVeri yok
Sridhar Narayan
Member of Scientific Advisory Boardno dataVeri yokVeri yok

5.5yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: APLI's board of directors are considered experienced (5.5 years average tenure).